Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience
- PMID: 38005877
- PMCID: PMC10674437
- DOI: 10.3390/v15112199
Country-Wide HCV Elimination Strategies Need to Reach Older Patients in the General Population: The Italian Experience
Abstract
HCV infection is still a major burden worldwide, and most countries are not on track to meet the WHO 2030 elimination goal. The current challenge is to identify individuals to be treated. In this study, we will describe the trend of new DAA prescriptions and the changes over time in terms of the characteristics of patients starting antiviral therapy in our unit. Data of 1646 hepatitis C patients who started therapy during the period of 2015-2022 regarding annual number of prescriptions, age, gender, nationality, HCV genotype, provenance, and liver disease severity were analyzed. We observed a peak in the number of new prescriptions in 2018 and a downward trend starting in 2019. Patients from the general population, centers for addictions, and prison differed significantly. The mean age in the general population remained above 60 years, the percentage of patients from centers for addictions and prison increased and, after 2016, there was no significant change in the percentage of patients with F3-F4 fibrosis. As HCV screening and linkage-to-care pathways seem to be already well implemented and successful in centers for addictions and in prisons, efforts need to be focused on those of older age in the general population. To carry this out, the more structured involvement of different health professionals must be figured out.
Keywords: HCV screening; hepatitis C; linkage-to-care; viral hepatitis elimination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.World J Gastroenterol. 2022 Jan 14;28(2):263-274. doi: 10.3748/wjg.v28.i2.263. World J Gastroenterol. 2022. PMID: 35110949 Free PMC article.
-
Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study.Addiction. 2020 May;115(5):901-913. doi: 10.1111/add.14830. Epub 2019 Nov 12. Addiction. 2020. PMID: 31633853
-
The effect of direct-acting antiviral regimens and telemedicine on the treatment of inmates with hepatitis C virus infection in Israeli prisons.Sci Prog. 2022 Apr-Jun;105(2):368504221105173. doi: 10.1177/00368504221105173. Sci Prog. 2022. PMID: 35722762 Free PMC article.
-
Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination Efforts.J Gen Intern Med. 2022 Oct;37(13):3435-3443. doi: 10.1007/s11606-022-07628-9. Epub 2022 Apr 28. J Gen Intern Med. 2022. PMID: 35484367 Free PMC article. Review.
-
Hepatitis C.Lancet. 2023 Sep 23;402(10407):1085-1096. doi: 10.1016/S0140-6736(23)01320-X. Lancet. 2023. PMID: 37741678 Review.
Cited by
-
Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years.Viruses. 2024 Nov 19;16(11):1792. doi: 10.3390/v16111792. Viruses. 2024. PMID: 39599906 Free PMC article. Review.
-
Evaluation of hyaluronic acid and type III procollagen peptide as predictors for treatment response to direct-acting antivirals.World J Virol. 2025 Jun 25;14(2):106479. doi: 10.5501/wjv.v14.i2.106479. World J Virol. 2025. PMID: 40575636 Free PMC article.
-
Spatiotemporal evolution of HCV burden among women of reproductive age: a multinational age-period-cohort analysis.Virol J. 2025 Aug 2;22(1):265. doi: 10.1186/s12985-025-02869-6. Virol J. 2025. PMID: 40753224 Free PMC article.
-
Trends in Hospitalizations of Patients with Hepatitis C Virus in Poland between 2012 and 2022.J Clin Med. 2024 Sep 22;13(18):5618. doi: 10.3390/jcm13185618. J Clin Med. 2024. PMID: 39337105 Free PMC article.
References
-
- Hepatitis C. [(accessed on 10 June 2023)]. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.
-
- CDA Foundation’s Polaris Observatory. [(accessed on 8 June 2023)]. Available online: https://cdafound.org/polaris-countries-dashboard/
-
- Rosato V., Kondili L.A., Nevola R., Perillo P., Mastrocinque D., Aghemo A., Claar E. Elimination of Hepatitis C in Southern Italy: A Model of HCV Screening and Linkage to Care among Hospitalized Patients at Different Hospital Divisions. Viruses. 2022;14:1096. doi: 10.3390/v14051096. - DOI - PMC - PubMed
-
- Morisco F., Loperto I., Stroffolini T., Lombardo F.L., Cossiga V., Guarino M., De Feo A., Caporaso N. Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades. J. Med. Virol. 2017;89:291–297. doi: 10.1002/jmv.24635. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous